Skip to main content
SpringerLink
Log in

Alectinib

Diarrhoea, elevated aminotransferase and elevated total bilirubin: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zou Z, et al. Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort. Translational Lung Cancer Research 11: 2495-2506, No. 12, 29 Dec 2022. Available from: URL: https://tlcr.amegroups.com/article/view/71044/html

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib. Reactions Weekly 1952, 35 (2023). https://doi.org/10.1007/s40278-023-37128-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37128-1

Search

Navigation